Titlebook: Genome Editing in Cardiovascular and Metabolic Diseases; Junjie Xiao Book 2023 The Editor(s) (if applicable) and The Author(s), under excl

染色體

Online Databases of Genome Editing in Cardiovascular and Metabolic Diseasese genetic background of these diseases allow new approaches to models and therapies, as well as different gene edition trials. Furthermore, technological improvements in gene editing go along with the development of new online and biocomputational tools that provide us alternative ways to explore pa

Truculent

博識(shí)

Genome Editing and Myocardial Development genetics involving an orchestrated series of genetic events and over 400 genes are responsible for myocardial development. Cooperation is required from a vast series of genetic networks, and mutations in such can lead to CHD and cardiovascular abnormalities, affecting up to 1% of all live births. G

gorgeous

阻礙

Genome Editing and Inherited Cardiac Arrhythmiasnosis is not always simple due to incomplete penetrance and genetic heterogeneity. Furthermore, the available treatments are usually invasive and merely preventive. Genome editing and especially CRISPR/Cas9 technologies have the potential to correct the genetic arrhythmogenic substrate, thereby offe